Willem Engel interviews Sasha Latypova about Toxicity of Experimental mRNA injections

https://whynotnews.eu/?p=494 ... Willem Engel interviews Sasha Latypova about Toxicity of the Phizer ingredients in Experimental mRNA injectionsShow more

~credits video: https://viruswaarheid.nl

Sasha Latypova short bio:

Most of Sasha Latypova professional experience is in pharma and medical industries with specific focus on development, validation, regulatory acceptance and commercialization of new clinical technologies.

Together with her business partners she build and grew successful technologically differentiated companies. Her role in the start-ups is typically in business development and strategic alliances. I have knowledge and experience in developing entirely new product/service lines from zero to scalable and profitable revenue streams. Sasha Latypova is also experienced in establishing strategic alliances with large pharma, medical device companies and strategic channel partners, as well as interacting with global healthcare regulators.

Specialties:

Entrepreneurship in pharma services/ clinical technologies; Clinical technology strategy; Clinical trials; Regulatory; Biomarker development and validation; Healthcare strategy including healthcare economics; Business development, strategic alliances.

https://www.linkedin.com/in/sashalatypova/